Powered by

Actavis to Acquire Auden Mckenzie for 306M GBP: - Vaults Actavis to #1 Position in UK Generics -

Jan 26, 2015 - PR Newswire
Mergers and Acquisitions

 Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company, and the owners of Auden Mckenzie Holdings Limited, a dynamic and fast growing company focused on the development, licensing and marketing of niche generic medicines and proprietary brands in the UK, today announced that they have reached a definitive agreement, under which Actavis will acquire Auden Mckenzie for approximately £306 million in cash, plus a two-year royalty on a percentage of gross profits of one of Aude...